Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Pressure BioSciences, Inc. (OTC: PBIO).

Full DD Report for PBIO

You must become a subscriber to view this report.


Recent News from (OTC: PBIO)

Pressure BioSciences Inc. (PBIO) Reports Significant Financial and Operational Achievements during Highly Successful Q2
Pressure BioSciences Inc. announced strong financial results for the second quarter of 2018, demonstrating the company’s growth and stability Products and services revenue increased for the tenth consecutive quarter (YoY) while registering growth of 29 percent compared to Q2 2017 ...
Source: NetworkNewsWire
Date: August, 16 2018 11:15
NetworkNewsBreaks - Pressure BioSciences Inc. (PBIO) Reports Q2 2018 Financial Results; Provides Business Update
Pressure BioSciences (OTCQB: PBIO) this morning provided a business update, offered limited guidance for the remainder of 2018 and reported financial results for the second quarter ended June 30, 2018. Per the update, total revenue for the second quarter was $638,800, an increase of 18% compar...
Source: NetworkNewsWire
Date: August, 15 2018 09:00
Pressure BioSciences, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
Major Debt to Equity Conversions, Increasing Revenues, and a Significant Operating Loss Decrease Highlight the 2018 Second Quarter Investor Conference Call Scheduled for Wednesday, August 15, 2018 at 4:30 PM EDT SOUTH EASTON, MA / ACCESSWIRE / August 15, 2018 / Pressure BioSc...
Source: ACCESSWIRE
Date: August, 15 2018 08:26
Pressure BioSciences, Inc. (PBIO) Receives Major Zacks Valuation Update
Zacks Small-Cap Research Report ups fair market value of PBIO stock by $2 per share Collaborative development project focused on liquid food preservation without chemical additives, extended shelf-life at room temperature and greater safety based upon PBIO’s patented Ultra Shear Te...
Source: NetworkNewsWire
Date: August, 10 2018 11:00
Pressure BioSciences, Inc. to Discuss Second Quarter 2018 Financial Results and Provide Business Update
SOUTH EASTON, MA / ACCESSWIRE / August 10, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (''PBI'' and the ''Company'') today announced that the Company will host a teleconference to discuss its Second Quarter 2018 financial results and to provide a business update. Anyone interested may li...
Source: ACCESSWIRE
Date: August, 10 2018 09:45
Pressure BioSciences, Inc. (PBIO) and Ohio State University Work on Groundbreaking Method to Preserve Foods and Beverages
Project backed by $891,000 grant from U.S. Department of Agriculture Ohio State gives Pressure BioSciences $318,000 contract to design and build “first-in-kind” bench-top and floor model Ultra Shear Technology equipment Game-changing technology could provide cost-effective...
Source: NetworkNewsWire
Date: August, 09 2018 12:00
Pressure BioSciences, Inc. President and CEO, Richard T. Schumacher, Discusses Recent Company Achievements with Everett Jolly on Uptick Newswire's "Stock Day" Podcast
PHOENIX, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire today announced the release of an interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (the “Company”) on Uptick Newswire’s “Stock Day” Podcast. The in...
Source: GlobeNewswire
Date: August, 09 2018 08:30
NetworkNewsBreaks - Pressure BioSciences Inc.'s (PBIO) UST Technology Could Transform Modern Food Preservation
Global life sciences company Pressure BioSciences’ (OTCQB: PBIO) patented Ultra Shear Technology (“UST”) is set to be utilized in the development of a groundbreaking manufacturing technology in a federally-funded research program focused on food preservation and safety at ...
Source: NetworkNewsWire
Date: August, 03 2018 10:45
Pressure BioSciences, Inc. (PBIO) Patented Ultra-Shear Technology Focus of New Government-Funded Food Safety Program
Federal four-year grant awarded to Ohio State University to fund research program with PBIO Goal is development of manufacturing process to keep foods fresh without costly refrigerated transport/storage and safe without chemical additives PBIO’s Ultra-Shear Technology (“US...
Source: NetworkNewsWire
Date: July, 26 2018 11:30
The MissionIR Newsletter Reports on ABCCF, FRSX, NETE, NUGL, PBIO, SNNVF, TGODF and TMSR
Every month, MissionIR issues a newsletter to update subscribers with regular updates on featured clients as well as relevant industry news effective the value of your portfolio. Here are the eight companies featured this month: The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) , whos...
Source: NetworkNewsWire
Date: July, 19 2018 12:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-193.933.974.003.384,234
2018-08-183.933.974.003.384,234
2018-08-173.933.974.003.384,234
2018-08-163.953.983.993.953,545
2018-08-153.903.954.003.702,720

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-173,6004,23485.0260Short
2018-08-162,5103,54570.8039Short
2018-08-152,4002,72088.2353Short
2018-08-1430030299.3377Short
2018-08-135,5468,43565.7499Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PBIO.


About Pressure BioSciences, Inc. (OTC: PBIO)

Logo for Pressure BioSciences, Inc. (OTC: PBIO)

Pressure BioSciences, Inc. OTCQB: PBIO develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated billion life sciences sample preparation market. Our products are based on the unique properties of both constant i.e., static and alternating i.e., pressure cycling technology, or PCT hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra high levels to safely and reproducibly control bio molecular interactions. To date, we have installed over PCT systems in approximately sites worldwide. There are over publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery amp design, bio therapeutics characterization, soil amp plant biology, vaccine development, histology, and counter bioterror applications.

 

 

 

Current Management

  • Richard T. Schumacher / CEO, President
  • Joseph L Damasio, Jr. / Acting CFO, VP, Fin.
  • Edmund Ting / Senior VP, Engineering
  • Alexander Lazarev / VP, R amp D
  • Nathan P. Lawrence / VP, Sales amp Mktg.
  • Jeffrey N. Peterson / Chairman, Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Vito J. Mangiardi / Independent Director, Audit Committee Member, Compensation Committee Member
  • Kevin A. Pollack / Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
  • Michael S. Urdea / Independent Director

Current Share Structure

  • Market Cap: $5,425,783 - 03/09/2018
  • Authorized: 100,000,000 - 08/31/2017
  • Issue and Outstanding: 1,154,422 - 11/07/2017
  • Float: 1,000,000 - 08/31/2017

 


Recent Filings from (OTC: PBIO)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 27 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 18 2017
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: November, 17 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017
When a company wishes to "uplist" from pinksheets to NASDAQ it must first file S-1 and S-1a until final approval. Once final approval is obtained the SEC files a CERTNAS
Filing Type: CERTNASFiling Source: edgar
Filing Date: August, 23 2017
Withdrawal of registration statement filed under the Securities Act
Filing Type: RWFiling Source: edgar
Filing Date: August, 15 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 14 2017

 

 


Daily Technical Chart for (OTC: PBIO)

Daily Technical Chart for (OTC: PBIO)


Stay tuned for daily updates and more on (OTC: PBIO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: PBIO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PBIO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of PBIO and does not buy, sell, or trade any shares of PBIO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/